潘托拉唑治疗消化性溃疡出血35例疗效观察

    Intravenous pantoprazole for the management of peptic ulcer hemorrhage: A clinical analyse of 35 cases

    • 摘要: 目的: 观察潘托拉唑治疗消化性溃疡出血的临床疗效。方法: 消化性溃疡出血患者65例,随机分为潘托拉唑组35例和奥美拉唑组30例。分别给予潘托拉唑80 mg、奥美拉唑40 mg静脉滴注,每天2次。观察其疗效和不良反应。结果: 潘托拉唑组与奥美拉唑组总有效率分别为94.3%和96.7%,两组疗效差异无统计学意义(P>0.05)。潘托拉唑组不良反应发生率(5.72%)低于奥美拉唑组(26.67%)(P<0.05)。结论: 潘托拉唑是治疗消化性溃疡出血的有效药物,且不良反应发生率低,值得在临床进一步推广应用。

       

      Abstract: Objective: To observe the clinical effect of intravenous pantoprazole、omeprazole for the management of peptic ulcer bleeding.Methods: Sixty-five patients with peptic ulcer bleeding were randomly divided into pantoprazole group(35 cases) and omeprazole group(30 cases).Which were administered intravenously pantoprazole(80 mg) and omeprazole(40 mg) twice daily respectively.To observe the clinical effective and adverse reaction.Results: There were no significant differences between The total effective rates of pantoprazole group and omeprazole group 94.3% vs 96.7%(P>0.05).But there were significant differences between the adverse reactions of pantoprazole group and omeprazole group 5.72% vs 26.67%(P<0.05).Conclusions: Intravenous pantoprazole is effective in the management of peptic ulcer bleeding and there's little adverse reaction.It is worthy further application in clinic.

       

    /

    返回文章
    返回